NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/26/2026
Back to search
Official data from USPTO
ZIPHIUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ZIPHIUS
ST13
US500000079366407Class
5, 9, 10, 35, 42, 44
Filing
79366407
Registration
7490625
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 9, 10, 35, 42, 44
Filing date
03/03/2023
Registration date
09/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/03/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
BE
Examiner
TURNER, JASON FITZGERALD
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ZIPHIUS
ZIPHIUS VACCINES NV
Representatives
Andrea S. Fuelleman Neal, Gerber & Eisenberg LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medicinal preparations and substances for the treatment of genetic disordersinfectious diseasesparasitic diseasesoncology in the field of cystic Fibrosischlamydia trachomatiseppstein barrherpes zosterherpes simplexcoronavirusesmalarialeishmaniasistrypanosomiasis; chikungunyadenguelymphatic filariasisrift valley feveryellow feverzikamalariaJapanese encephalitisWest Nile feverschistosomiasis (bilharziasis)Onchocerciasis (river blindness)plaguestungiasistyphuslouse-borne relapsing feverLeishmaniasisSandfly fever (Phlebotomus fever)Crimean Congo haemorrhagic feverLyme diseaseRelapsing fever (borreliosis)rickettsial diseasesTick-borne encephalitistularaemiachagas disease (American trypanosomiasis)sleeping sickness (African trypanosomiasis)all of the foregoing based on self-amplifying RNA and Lipid based delivery vehicles; vaccines
Class 9
Downloadable mobile applications and downloadable computer software to enable healthcare professionals and patients to access information on pharmaceuticalmedical and vaccine products and services; Downloadable e-commerce software to enable users to perform electronic business transactions via a global computer network; Downloadable computer software to enable professionals to optimize workflowcapture and organize informationplace orders and track expenses
Class 10
Surgical apparatus and instruments for medical use; blood pressure and diabetic diagnostic medical devices
Class 35
Provision of information and advisory services relating to electronic commerce; provision of customer information on pharmaceutical and medical products through an on-line computer network for advertising purposes
Class 42
Scientific research for medical purposes
Class 44
Medical services and healthcare services namelyoffered through a network of healthcare providers on a contract basis; provision of medical information; provision of medical information to patients and healthcare professionals concerning pharmaceutical productsvaccinesmedical diseases and disorders and related treatments via the Internet; gene therapy and stem cell therapy services; medical and psychological counselling services; medical and pharmaceutical consultation; medical diagnostic testingmonitoring and reporting services; genetic testing for medical purposes
Publications
History of USPTO decisions and trademark events.
34 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/13/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/08/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/18/2025
FIMP
FINAL DISPOSITION PROCESSED
02/18/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/03/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/28/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/14/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/03/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/28/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/28/2024
GPNX
NOTIFICATION PROCESSED BY IB
07/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/18/2024
PUBO
PUBLISHED FOR OPPOSITION
06/18/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/11/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/29/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/16/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/14/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/14/2024
RFNT
REFUSAL PROCESSED BY IB
01/02/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/11/2023
RFRR
REFUSAL PROCESSED BY MPU
12/11/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/08/2023
CNRT
NON-FINAL ACTION WRITTEN
12/07/2023
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
12/04/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/03/2023
CNRT
NON-FINAL ACTION WRITTEN
12/02/2023
DOCK
ASSIGNED TO EXAMINER
12/02/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/30/2023
Continuous trademark protection
Get notified about every new filing that threatens ZIPHIUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.